It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
A renowned research professor in France has reported successful results from a new treatment for Covid-19, with early tests suggesting it can stop the virus from being contagious in just six days.
Professor Raoult is an infectious diseases specialist and head of the IHU Méditerranée Infection, who has been tasked by - and consulted by - the French government to research possible treatments of Covid-19.
He said that the first Covid-19 patients he had treated with the drug chloroquine had seen a rapid and effective speeding up of their healing process, and a sharp decrease in the amount of time they remained contagious.
A new academic study, published on Friday March 13 by US scientific researchers, also said that chloroquine appeared to be an effective treatment, and appears to align with the findings in France.
It said: “Use of chloroquine (tablets) is showing favorable outcomes in humans infected with Coronavirus including faster time to recovery and shorter hospital stay…
“Research shows that chloroquine also has strong potential as a prophylactic (preventative) measure against coronavirus in the lab, while we wait for a vaccine to be developed.
“Chloroquine is an inexpensive, globally available drug that has been in widespread human use since 1945 against malaria, autoimmune and various other conditions…[it] can be prescribed to adults and children of all ages.
More at: www.newsweek.com...
The U.S. Department of Justice on Monday cited "extreme urgency" in clearing U.S. pharmaceutical distributors from legal hurdles in order to provide the anti-malaria drug Hydroxychloroquine to coronavirus patients.
The Justice Department penned a response letter Monday notifying one of the country's largest wholesale drug distribution companies, AmerisourceBergen, that antitrust hurdles have been removed as part of an "expedited, temporary review procedure."
The DOJ letter dated April 20th, says the drug corporation is now set to work with federal government agencies and health care providers to distribute hydroxychloroquine to patients with coronavirus symptoms.
The anti-malaria drug has been controversially touted by President Donald Trump as a "treatment" for COVID-19, the illness caused by the novel coronavirus, despite reports from organizations including the American Heart Association that the medication exacerbates fatal heart problems and has not faced U.S. clinical trials.
But the Monday DOJ letter indicates the drug's distribution is now being fast-tracked and allows AmerisourceBergen, which was sued in 2017 for allegedly worsening the opioid drug crisis, to temporarily "act as the U.S. Government's hydroxychloroquine distribution agents" without legal concern over antitrust violations as they address supply chain shortages.
"One initiative is the distribution of hydroxychloroquine from the Stockpile to health care providers in areas of greatest need," reads the Justice Department letter from Assistant Attorney General Makan Delrahim. "In this distribution initiative, AmerisourceBergen and other distributors act as the U.S. Government's distribution agents. The U.S. Government will instruct AmerisourceBergen on the amount of hydroxychloroquine it will receive and where the hydroxychloroquine is to be sent."
Dr. William Grace told Ingraham that they have 100 patients and have had zero deaths after the use of Hydroxychloroquine.
Hydroxychloroquine is the less toxic version of Chloroquine.
Grace said that a big reason older people die from the coronavirus is that their lungs fill up with fluid as part of an immune response to the virus. Hydroxychloroquine works, Grace notes, in both inhibiting the immune response and inhibiting the replication of the virus.
New York Gov. Andrew Cuomo (D) says that early responses to the antimalarial drug hydroxychloroquine "anecdotally" suggest its use in the coronavirus fight has been "effective."
An “Islamic medicine specialist” from Iran urged Iranians to drink camel urine, claiming it can cure several diseases including coronavirus
originally posted by: carewemust
New York Governor Andrew Cuomo met with President Trump in the white house yesterday.
New York Gov. Andrew Cuomo (D) says that early responses to the antimalarial drug hydroxychloroquine "anecdotally" suggest its use in the coronavirus fight has been "effective."
twitter.com...
originally posted by: Grimpachi
Coronavirus: Chloroquine study in Brazil aborted after deaths
More deaths, no benefit from malaria drug in VA virus study
Antimalarials widely used against COVID-19 heighten risk of cardiac arrest. How can doctors minimize the danger?
Study of High-Dose Chloroquine For COVID-19 Stopped Early Due to Patient Deaths
Study finds no benefit, higher death rate in patients taking hydroxychloroquine for Covid-19
NIH Panel Recommends Against Drug Combination Promoted By Trump For COVID-19
NIH recommends against using hydroxychloroquine with azithromycin to treat coronavirus
originally posted by: Grimpachi
originally posted by: carewemust
New York Governor Andrew Cuomo met with President Trump in the white house yesterday.
New York Gov. Andrew Cuomo (D) says that early responses to the antimalarial drug hydroxychloroquine "anecdotally" suggest its use in the coronavirus fight has been "effective."
twitter.com...
Did you not realize your twitter source references are from 3 weeks ago.
New York Gov. Andrew Cuomo (D) says that early responses to the antimalarial drug hydroxychloroquine "anecdotally" suggest its use in the coronavirus fight has been "effective."
The Food and Drug Administration strongly warned Friday against using hydroxychloroquine or a related compound, chloroquine, for treating or preventing COVID-19 without strict medical supervision in a hospital or as part of a clinical trial. The agency said its officials have not approved the anti-malaria drugs for that purpose — and that without close monitoring for side effects, they may lead to life-threatening complications.